Send me a link:

*Text messaging rates may apply.

 Dow Up 0.36% Nasdaq Up 0.71%

Acorda Therapeutics, Inc. (ACOR)

-NasdaqGS
29.75 0.13(0.44%) Jul 22, 4:00PM EDT
Prev Close:29.88
Open:30.11
Bid:27.50 x 100
Ask:32.46 x 100
1y Target Est:39.81
Beta:1.78
Earnings Date:Jul 31 - Aug 4 (Est.)
Day's Range:29.71 - 30.76
52wk Range:27.51 - 39.95
Volume:321,597
Avg Vol (3m):600,535
Market Cap:1.22B
P/E (ttm):68.71
EPS (ttm):0.43
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ACORDown 0.44%1.22B
BIIB72.03B
TEVA46.75B

Key Statistics

Forward P/E (1 yr):39.67
P/S (ttm):3.55
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.40
Quarterly EPS Est (Jun-14) :0.14
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):4.67

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for multiple sclerosis (MS), spinal cord injury (SCI), and other disorders of the nervous system in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback